Primary Hyperparathyroidism
55 y/o F with h/o neck radiation, nephrolithiasis, long-bone fractures presents, bipolar disorder for health maintenance exam. Reports intermittent lethargy/fatigue, weakness, epigastric pain, nausea/vomiting, insomnia, and forgetfulness. Medications include lithium. Hypertension, irregular heartbeat, abdominal tenderness, flank pain, muscle weakness, and lower extremity edema on exam.
CMP shows hypercalcemia
Repeat CMP and re-evaluate serum calcium and creatinine levels
If repeat serum calcium elevated, obtain serum ionized calcium
Obtain serum vitamin D, magnesium, and lithium levels
PTH > 65 mg/dL in setting of hypercalcemia: Obtain 24-hour urine calcium:urine creatinine ratio
Ratio > 0.01: Primary hyperparathyroidism confirmed
Obtain Sestamibi scan to confirm hyperparathyroidism due to excess parathyroid activity and refer for surgical removal of parathyroid glands pending positive scan
Consider genetic analysis for MEN syndrome
Ratio 0.01 or less: Diagnose familial hypocalciuric hypercalcemia (see notes below)
Notes
Risk factors include female sex, age > 50 years, and h/o neck radiation
Presentation
Most patients are asymptomatic at diagnosis
Elements of the classic stones (nephrolithiasis), bones (osteitis fibrosa cystica), groans (abdominal pain due to pancreatitis), and psychiatric overtones (lethargy/fatigue, weakness, insomnia, impaired memory) may be present
Hyperparathyroidism is sometimes associated with hypertension, arrhythmia, heart failure, and muscle weakness
Diagnosis
Primary hyperparathyroidism is most commonly an incidental diagnosis
Low vitamin D and/or calcium levels may cause hypoglycemia and lead to elevated parathyroid hormone in the setting of low to normal calcium values
Lithium can raise PTH levels, thereby causing hypercalcemia; chronic use may also lead to renal failure and associated hypocalcemia due to decreased vitamin D production
Familial hypocalciuric hypercalcemia
This condition is due a “calcium sensor that reads low.” In other words, a normal sensor shuts off PTH when the calcium level reaches ~9.0 mg/dL, i.e. normal. In patients with familial hypocalciuric hypercalcemia, the sensor doesn’t activate until calcium levels reach ~11.0 or higher, i.e. elevated.
Patients may not need surgical removal of parathyroid glands if they are not displaying signs/symptoms of hyperparathyroidism
If PTH is low, primary hyperparathyroidism is ruled out: Obtain 25-hydroxyvitamin D, 1,25-hydroxyvitamin D, and PTH-rP level to evaluate for parathyroid-independent causes of hypercalcemia
Secondary Hyperparathyroidism
Pt with h/o chronic kidney disease, bipolar disorder controlled with lithium, and h/o gastric bypass surgery presents with hypocalcemia. Reports recent paresthesias, emotional lability, anxiety/depression, and difficulty focusing. Hypotension, cataract, lower extremity edema, positive Chvostek/Trousseau sign, and dry skin on exam.
Labs
CMP shows hypocalcemia with normal albumin
Obtain repeat CMP
If repeat CMP shows hypocalcemia, obtain serum ionized calcium
PTH > 65 mg/dL
Obtain 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 levels
Obtain EKG and evaluate QTc
Start vitamin D and/or calcium supplementation as needed to prevent osteomalacia
Pt counseled about importance of vitamin supplementation s/p bariatric surgery
Notes
Etiology
Renal failure = most common etiology
May occur due to chronic lithium use
Decreases conversion of 25-hydroxyvitamin D3 to the active 1,25-dihydroxyvitamin D3
May be related to decreased vitamin D and/or calcium absorption, e.g. due gastric bypass surgery
Insufficient calcium intake is rare in developed nations
Normal values
PTH 10-65 mg/dL
25-hydroxyvitamin D > 10 ng/mL